Cancer (Oncology)

Lenvat 4® Lenvatinib Capsules
Lenvatinib 4mg
- Composition
- Lenvatinib 4mg
- Dosage form
- Capsules
- Pack size
- Bottle of 30 Capsule
- Manufacturer
- Natco
- Also known as
- Lenvima
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Lenvat 4 mg contains lenvatinib, a targeted anticancer medicine used to treat certain types of thyroid, liver, kidney and endometrial cancers. It works by inhibiting proteins involved in tumour growth and the development of blood vessels that supply cancer cells.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Related products
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
Cancer (Oncology)
